Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-23

Clinical Trial Update: Remimazolam Consumption: TCI vs. Manual Infusion [NA]

View source ↗

Summary

A clinical trial is recruiting to compare remimazolam delivery methods (target-controlled infusion vs manual infusion) in Moyamoya disease. The study is sponsor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remimazolam (remimazolam)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Moyamoya Disease | NA | Status: RECRUITING